Position: Director of Domestic Oncology Wards
Title: Chief Physician
Specialty: Treatment of advanced hepatocellular carcinoma, cancerous pleural effusion and middle and advanced cancer as well as hematological diseases.
Introduction:
Director Li Xiaoshi has more than 40 years of medical experience and has accumulated rich clinical experience in the field of oncology and internal medicine, especially for various malignancies (head and neck cancer, lung cancer, esophageal cancer, stomach cancer, colon cancer, liver cancer, pancreatic cancer, bladder cancer, gynecological cancer, etc.), and hematological diseases, leukemia, lymphoma, myeloma and other diseases.
He is specialized in applying a variety of effective comprehensive therapies for cancer treatment, such as percutaneous puncture and topical medication, systemic and thoracic and intraperitoneal chemotherapy, and a variety of local treatment techniques (ultrasonic knife, argon helium knife, radiofrequency ablation, particle implantation and photodynamic therapy, etc.). which benefit plenty of cancer patients at home and abroad.
Educational Background:
During 1975-1978, Li Xiaoshi was studying in Norman Bethune University of Medical Science. While during 1992-1995, he was studying for a master’s degree in Medical College of Soochow University.
Medical experience:
1995-1999: Director of Blood Oncology and Deputy chief physician of radiotherapy division in General Hospital of Jinlin Oil Field
1999-2002: Chief physician, Director of Hematology Oncology and Director of Biological Therapy Room in Changshu first People's Hospital, Jiangsu Province
2002-2013: Chief physician, Director of Oncology in Shenzhen Nanshan Hospital (blood), Guangdong province
2013-present: Chief physician, Director of domestic Oncology Wards, Modern Cancer Hospital Guangzhou
Research Field:
Hematology and Oncology
Monograph:
《Health Guide for Oil Workers》
《Handbook of Bone Marrow Examination》
*Surgery, in addition to the appropriate chemotherapy and radiotherapy, are effective in treating early cancer, but certain patients in late stage of cancer may not be tolerate surgery well as they can be relatively weak. A combination of carefully planned minimally invasive therapy, chemotherapy or radiotherapy can effectively reduce the side effects and discomfort of treatment and may help patient get better efficacy.